Pharma

All articles by Pharma

Five things for pharma marketers to know: Friday, January 27, 2023
Five things for pharma marketers to know: Friday, January 27, 2023
Jack O'Brien
January 27, 2023
5:00 am

Congress eyes PBMs; Abzena lays off 80; Concentra builds financial penalties into contract clauses to discourage workers from leaving.

Aaron Rodgers calls out Big Pharma over 2021 COVID-19 vaccine controversy
Aaron Rodgers calls out Big Pharma over 2021 COVID-19 vaccine controversy
Jack O'Brien
January 26, 2023
10:33 am

Rodgers, a four-time NFL MVP, made the comments about not receiving the COVID-19 vaccine during an appearance on The Pat McAfee Show on Tuesday.

Five things for pharma marketers to know: Thursday, January 26, 2023
Five things for pharma marketers to know: Thursday, January 26, 2023
Lecia Bushak
January 26, 2023
5:00 am

Merck stops Keytruda trial for prostate cancer; Pharma CEOs doubt Mark Cuban’s efforts to upend drug industry; Novartis fined $2.8 million by Belgian antitrust regulators over Lucentis.

Former Biogen CEO George Scangos retires after 40-year pharma career
Former Biogen CEO George Scangos retires after 40-year pharma career
Lecia Bushak
January 25, 2023
12:49 pm

Scangos is stepping down after leading Vir Biotechnology’s efforts to develop COVID-19 antibody sotrovimab.

Days after DOJ opens criminal probe over infant formula, Abbott releases 2022 financials
Days after DOJ opens criminal probe over infant formula, Abbott releases 2022 financials
Jack O'Brien
January 25, 2023
10:20 am

Domestic sales of certain infant formula products affected by the manufacturing disruptions totaled $479 million for 2022, down from $1.22 billion for 2021.

Five things for pharma marketers to know: Wednesday, January 25, 2023
Five things for pharma marketers to know: Wednesday, January 25, 2023
Lecia Bushak
January 25, 2023
5:00 am

FDA to hold an expert panel to define the process for updating COVID-19 vaccines annually; Finch Therapeutics halts Phase III trial for stool-in-a-capsule treatment, lays off most staff; Long COVID is keeping a significant number of people out of work.

Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility
Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility
Lecia Bushak
January 24, 2023
4:25 pm

The move is meant to increase capacity for diabetes drugs including Trulicity and Mounjaro, which have experienced shortages in recent months.

Lower COVID-19 vaccine sales contribute to quarterly decline for J&J
Lower COVID-19 vaccine sales contribute to quarterly decline for J&J
Jack O'Brien
January 24, 2023
11:04 am

For the full-year, J&J reported sales growth of 1.3% and operational growth of 6.1%.

Takeda plunks down $400M for ex-China rights to Hutchmed cancer drug
Takeda plunks down $400M for ex-China rights to Hutchmed cancer drug
Marc Iskowitz
January 23, 2023
12:15 pm

The Takeda deal terms also include up to $730 million in potential milestone and royalty payments.

Five things for pharma marketers to know: Monday, January 23, 2023
Five things for pharma marketers to know: Monday, January 23, 2023
Jack O'Brien
January 23, 2023
5:00 am

Sinopharm’s biotech unit receives approval for clinical trials of mRNA COVID vaccine; Prosecutors argue Elizabeth Holmes should be in prison, not luxurious estate; Former President Trump allegedly told former Secretary of State Mike Pompeo to ‘shut the hell up’ about China.

  • From Our Partners